Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
rx-10045 (1 trial)
Dry Eye Syndromes (Phase 2)
Keratoconjunctivitis Sicca (Phase 2)
Signs and Symptoms (Phase 2)
Trials (1 total)
Trial APIs (1 total)